We are a biotech company developing treatments for advanced-stage skin cancer. Our non-invasive investigational therapies are designed to destroy solid tumors and metastatic cancer and preserve quality of life.

OncoSec_ImmunoPulse_new

IMMUNOPULSE

FIGHTING CANCER WITH THE BODY’S IMMUNE SYSTEM

Using DNA IL-12, ImmunoPulse is designed to stimulate the body’s immune system and enable it to recognize, target, and destroy cancerous cells.

AN INTROSPECTIVE ON IMMUNOTHERAPY

A SYMPOSIUM ON INTRAMURAL THERAPY

Learn more about the exciting field of intratumoral immunotherapy and OncoSec’s role as a key leader in this emerging space.

Download our Investor Overview:

* indicates required field

Subscribe to Our Newsletter:


Be the first to hear about new progress and breakthroughs at OncoSec.